Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Report on Manager's Transactions in Dampskibsselskabet NORDEN A/S

ANNOUNCEMENT NO. 160 - 19 AUGUST 2022   Under Article 19 of the Market Abuse Regulation Dampskibsselskabet NORDEN A/S is required to report transactions in Dampskibsselskabet NORDEN A/S’ shares by persons discharging managerial responsibilities and their close relatives.     Name:   Jan RindboReason:   Reporting duty, CEOIssuer:   Dampskibsselskabet NORDEN A/SISIN code:   DK0010269844Instrument:   SharesTransaction:   SaleTrading date:   18

Crown Energy: Q2 report January-June 2022

SECOND QUARTER REPORT – APRIL-JUNE 2022 · Revenue amounted to SEK 10,334 thousand (5,683). · Operating loss amounted to SEK -7,467 thousand (-8,461). · Net financial items amounted to SEK 2,328 thousand (5,925). · Unrealised changes in property values amounted to SEK 2,931 thousand (-5,891). · Result before tax amounted to SEK -2,207 thousand (-8,426) and result after tax amounted to SEK -17,509 thousand (-8,669), corresponding to SEK -0.04(-0.02) per share.      HALF YEAR REPORT – JANUARY-JUNE 2022 ·  Revenue amounted to SEK 17,647 thousand (10,562). ·

Nordea Bank Abp: Repurchase of own shares on 19.08.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares19.08.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 19.08.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number Weighted average Total cost, EUR* **venue (MIC of price / share, EUR* Code) shares **XHEL 255,924 9.66 2,471,509.25CEUX 248,595 9.65 2,398,524.82TQEX 0 - 0.00XSTO 282,514 9.64 2,723,280.92XCSE

DanCann Pharma A/S postpones quarterly report for Q2 2022

COPENHAGEN, Denmark, 19 August 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the board of directors of DanCann Pharma has decided to postpone the report for the second quarter until Wednesday, August 31, 2022. The previous date was set for August 25, 2022.About DanCann Pharma DanCann Pharma A/S (SS: DANCAN) was founded in 2018 and is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a vertically integrated, licensed production and distribution Company based in Denmark.

Borr Drilling Limited - Exercise of Option to Purchase Additional Shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Hamilton, Bermuda, August 19, 2022. Borr Drilling Limited (the “Company”) (NYSE and OSE: BORR) announces today that the underwriters of the Company’s previously announced US offering of its US common shares (the “Offering”) have exercised their option to purchase an additional 6,918,627 common shares at the public offering

Elkem ASA - Buyback of shares

Oslo, 19 August 2022 Please see below information about transactions made under the share buyback programme for Elkem ASA. · Date on which the buyback programme was announced: 21 July 2022 · The duration of the buyback programme: 21 July 2022 to 23 September 2022 · Size of the buyback programme: Up to 5,000,000 shares From 13 August 2022 until 19 August 2022, Elkem ASA has purchased a total of 625,000 own shares at the Oslo Stock Exchange at an average price of NOK 37.4080 per share. Aggregated overview of transactions per day: Date Aggregated Weighted

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 19.08.2022

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION    19.08.2022 at 18:30 EET   ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 19.08.2022   Date 19.08.2022  Exchange transaction Buy  Share class ALEX  Amount 250  Average price/share 8.2000   EURHighest price/share 8.2000   EURLowest price/share 8.2000   EURTotal price 2,050.00 EUR        The shares held by Alexandria Pankkiiriliike Oyj on 19.08.

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 19.08.2022

Fiskars Corporation   Stock Exchange Release 19.08.2022 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 19.08.2022   Date 19.08.2022  Exchange transaction Buy  Share class FSKRS  Amount  6,500  Average price/share 18.5001 EURHighest price/share 18.5800 EURLowest price/share 18.3000 EURTotal price 120,250.65 EUR        The shares held by Fiskars Corporation on 19.08.2022:   FSKRS 969,405       On

Metso Outotec Corporation: SHARE REPURCHASE 19.8.2022

Metso Outotec Corporation  ANNOUNCEMENT  19.8.2022 Metso Outotec Corporation: SHARE REPURCHASE 19.8.2022 In the Helsinki Stock Exchange Trade date           19.8.2022Bourse trade         BuyShare                  MOCORPAmount             350 000 SharesAverage price/ share    8,2437 EURTotal cost            2 885 295,00 EUR Metso Outotec Corporation now holds a total of 3 038 505 sharesincluding the shares repurchased on 19.8.2022 On behalf of Metso Outotec Corporation

Notification of trades

Reference is made to Aker BP's press release from 8 August 2022, where the company announced its plan to buy up to 1,000,000 own shares in connection with the company's employee share saving plan. In the period from 15 August to 19 August, the company purchased 250,000 shares at an average price of NOK 324.35. An overview of the transactions, and a detailed specification of each individual trade, are attached to this announcement and available at www.newsweb.no. After these transactions, Aker BP ASA owns a total of 775,655 own shares, corresponding to 0.12 percent of the company's

CS MEDICA A/S: Based on a dialog with a European based veterinarian company, their vet product line is pulled forward- engaging a targeted marked of US$1 billion/yearly

CS MEDICA A/S (“CS MEDICA” or “the Company”) announces today that the Company have entered in dialog with a European based veterinarian company, with a long track record, branding their products to veterinary practices throughout Europe. The Company is hereby looking into entering the veterinarian market with the Company’s Veterinary Medical CBD Products before schedule.CS MEDICA have brought effective medical CBD products to humans, and now they want to utilize their knowledge of effective Medical CBD Products by bringing the veterinarian (vet) Medical CBD Products to the family’s best

Acroud publishes bond prospectus and applies for admission to trading of its bonds on Nasdaq Stockholm

On 5 July 2022, Acroud AB (publ) (“Acroud”) issued senior secured bonds 2022/2025 with ISIN SE0017562481 in the total amount of SEK 225,000,000 (the “Bonds”). In accordance with the terms and conditions of the Bonds, Acroud has applied for admission to trading of the Bonds on the corporate bond list at Nasdaq Stockholm and the first day of trading at Nasdaq Stockholm is expected to be on 23 August 2022. For the purpose of the admission to trading, Acroud has prepared a listing prospectus which today has been approved by the Swedish Financial Supervisory Authority. The prospectus will be

Trading of own shares as part of employee’s savings scheme

SpareBank 1 SR-Bank ASA has on 19 August 2022 purchased 25 334 own shares at an average price of 118.7269. Total holdings of own shares after the purchase is 106 024 shares. The shares were acquired as part of SpareBank 1 SR-Bank’s savings scheme for employees. For more information about the saving scheme reference is made to the stock exchange notice dated 20 December 2021, and the stock exchange notice dated 28 April 2022.

#22-287 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#22-286 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

SkartaNYAB Plc lowers financial guidance for 2022 and publishes preliminary information on key figures of the first half of the year

SkartaNYAB PlcCOMPANY ANNOUNCEMENT, INSIDE INFORMATION19 August 2022 at 17:00SkartaNYAB Plc lowers financial guidance for 2022 and publishes preliminary information on key figures of the first half of the year SkartaNYAB Plc changes its financial guidance for 2022. According to the new guidance of the company, revenue of the group for financial year 2022 is estimated to be 225-245 million euros, and operating profit without amortization and reduction in value of intangible assets (EBITA) 14-20 million euros. In previous guidance that was published in Q1 business review on 13 May 2022,

Betsson issues subsequent bonds of EUR 10 million

Betsson AB (publ) (the “Company”) has successfully issued subsequent senior unsecured bonds of EUR 10,000,000 under the Company’s outstanding framework of EUR 250,000,000 with ISIN SE0017769672. After the issue, a total volume of EUR 100,000,000 will be outstanding under the framework.   The subsequent bonds were priced at 100.0 percent and run with a floating interest rate of EURIBOR three months plus 650 bps with final maturity in June 2025. The proceeds will be used for general corporate purposes. Nordea has acted as sole bookrunner in connection with the issue and Gernandt &

Checkin.com Group: Webcast of Quarterly Report Q2 2022 Thursday August 25th 08.30 CEST

Thursday August 25th 07.30 CEST Checkin.com Group publishes the quarterly report for Q2 2022 on the company’s website. In a webcast the same day at 08.30 CEST the report will be presented by the company’s CEO Kristoffer Cassel and CFO Martin Bäuml. The webcast (Swedish) will be available through this link:https://www.finwire.tv/webcast/checkin-com/2022-q2/The full report, in Swedish and English, will be published on:https://group.checkin.com/investors/reports/ An english version of the webcast will be published on the company’s website later the same day.  For further

Corem signs a lease contract with 101 Studios in New York

 Photograph: Michel Young  Corem has signed a lease contract with 101 Studios for approximately 770 sq.m. of office space at the project property 1245 Broadway in New York. The tenant, an American entertainment company active in producing series for television, will move in during the spring of 2023 and the lease term is 12 years.1245 Broadway, a 23-story modern office building located at the corner of 31st Street and Broadway in Manhattan, is Corem’s largest ongoing project and is being developed in collaboration with GDS Development Management (GDSNY). The building will be

Invitation to phone conference with webcast in conjunction with the release of the Instalco Q2 2022 report

Instalco will release its Interim report Q2 2022 on 25 August at 11:00 CET. Instalco will also be presenting the report in a phone conference with webcast at 14:00 on the same day.Robin Boheman, CEO and Christian Kassberg, CFO will be presenting and commenting on the report.     Publication of the Q2 2022 report 11:00 CEThttps://instalco.se/en/investors/financial-reports   Phone numbers for joining the telephone conference at 14:00 CETSE: +46 8 505 583 69 UK: +44 333 300 92 70 US: +1 646 722 49 56  Link to the webcast, 14:00 CEThttps://tv.streamfabriken.com/

Top 6 real money online casino sites in India

A real money online casino in India used to be hard to come by. However, with the Indian government choosing not to legally prohibit online gambling, online casino games have soared in popularity in recent years. These sites give you a chance to play popular card games like blackjack or spin the reels of online slot games that are household names elsewhere in the world. If you want to know the best online casino in India for real money gaming, you’ve come to the right place.Best real money casino sites of 2022  [Genesis Casino] 

Kyoto Group AS: Presents first half 2022 results on Thursday 25 August

Lysaker, 19 August 2022 Kyoto Group AS will release its financial results for the first half year of 2022 on 25th August at 07:00 CEST.CEO Camilla Nilsson and CCO Tim de Haas will present the company's results at 10:00 CEST and invite investors, analysts and media to join the live webcast presentation. The presentation is expected to last up to one hour, including Q&A, and can be followed via live webcast. Webcast: Please register to join the results webcast via the following link: www.kyotogroup.no/half-year-report-2022 Questions can be submitted through the online webcast

Inify Laboratories - mandatory notification of trade

Stockholm, Sweden, August 19, 2022; Inify Laboratories AB ("Inify") has been notified that the following transaction has been completed by a close associate to a primary insider in Inify: Monsun AS, a Norwegian company controlled by Magne Jordanger, board member and primary insider in Inify, has bought 336,950 shares in Inify at an average price of NOK 7.6 per share. After the transaction, Monsun AS holds 336,950 shares. Please refer to the attached notification of trading for further details. This information is subject to the disclosure requirements in the EU Market Abuse Regulation (

There are no items matching the current filter
There are no more items matching the current filter
Back to top